Mydecine Innovations Group

About:

Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders.

Website: https://mydecineinc.com/

Description:

Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders. They use a world-class technology and drug development infrastructure, and advances new treatment options in areas of significant unmet need. Founded in 2020, the company is based in Vancouver, British Columbia, Canada.

Total Funding Amount:

$7.55M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

2013-09-27

Contact Email:

info(AT)mydecineinc.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2023-09-15

IPO Status:

Public

Industries:

© 2025 bioDAO.ai